Aragon Pharmaceuticals' Acquisition

Aragon Pharmaceuticals was acquired by Johnson & Johnson on August 19, 2013.

Aragon Pharmaceuticals is a small-molecule drug discovery company focused on developing medicines for the treatment of hormonally-driven cancers. These cancers eventually become resistant to existing …

Articles about Aragon Pharmaceuticals' Acquisition: